Use of fluorescence in situ hybridization to predict response to bacillus Calmette-Guérin therapy for bladder cancer: Results of a prospective trial

Journal of Urology

Volumn 187, Issue 3, 2012, Pages 862-867

  Kamat, Ashish M ^a   Dickstein, Rian J ^a   Messetti, Fabrizio ^a   Anderson, Roosevelt ^a   Pretzsch, Shanna M ^a   Gonzalez, Graciela Noguera ^a   Katz, Ruth L ^a   Khanna, Abha ^a   Zaidi, Tanweer ^a   Wu, Xifeng ^a   Grossman, H Barton ^a   Dinney, Colin P ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

fluorescence; in situ hybridization; mycobacterium bovis; prognosis; treatment outcome; urinary bladder neoplasms

Indexed keywords

BCG VACCINE;

AGED; ARTICLE; BLADDER CANCER; CANCER GROWTH; CANCER IMMUNIZATION; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; DRUG RESPONSE; DRUG TREATMENT FAILURE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HUMAN; HUMAN CELL; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NONMUSCLE INVASIVE BLADDER CANCER; PATIENT MONITORING; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENCE FREE SURVIVAL; TREATMENT DURATION; URINALYSIS;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRAVESICAL; AGED; BCG VACCINE; DISEASE PROGRESSION; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KAPLAN-MEIER ESTIMATE; MALE; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84862829088     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.10.144     Document Type: Article

References (20)

1. A. Jemal, R. Siegel, J. Xu Cancer statistics, 2010 CA Cancer J Clin 60 2010 277
2. N.M. Heney, S. Ahmed, M.J. Flanagan Superficial bladder cancer: progression and recurrence J Urol 130 1983 1083
3. A.M. Kamat, D.L. Lamm Immunotherapy for bladder cancer Curr Urol Rep 2 2001 62
4. H.W. Herr, P.C. Sogani Does early cystectomy improve the survival of patients with high risk superficial bladder tumors? J Urol 166 2001 1296
5. G. Dalbagni, T. Rechtschaffen, H.W. Herr Is transurethral biopsy of the bladder necessary after 3 months to evaluate response to bacillus Calmette-Guerin therapy? J Urol 162 1999 708
6. R.A. Highshaw, S.T. Tanaka, C.P. Evans Is bladder biopsy necessary at three or six months post BCG therapy? Urol Oncol 21 2003 207
7. L. Bubendorf, B. Grilli UroVysion multiprobe FISH in urinary cytology Methods Mol Med 97 2004 117
8. B.R. Kipp, R.J. Karnes, S.M. Brankley Monitoring intravesical therapy for superficial bladder cancer using fluorescence in situ hybridization J Urol 173 2005 401
9. L. Mengual, M. Marn-Aguilera, M.J. Ribal Clinical utility of fluorescent in situ hybridization for the surveillance of bladder cancer patients treated with bacillus Calmette-Guérin therapy Eur Urol 52 2007 752
10. J. Whitson, A. Berry, P. Carroll A multicolour fluorescence in situ hybridization test predicts recurrence in patients with high-risk superficial bladder tumours undergoing intravesical therapy BJU Int 104 2009 336
11. S. Savic, I. Zlobec, G.N. Thalmann The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy Int J Cancer 124 2009 2899
12. R.J. Sylvester, A.P. van der Meijden, W. Oosterlinck Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials Eur Urol 49 2006 466
13. D.L. Lamm, B.A. Blumenstein, J.D. Crissman Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study J Urol 163 2000 1124
14. M.A. O'Donnell, K. Lilli, C. Leopold Interim results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon alfa-2b for superficial bladder cancer J Urol 172 2004 888
15. T. Zellweger, G. Benz, G. Cathomas Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer Int J Cancer 119 2006 1660
16. N.P. Caraway, A. Khanna, R.L. Fernandez Fluorescence in situ hybridization for detecting urothelial carcinoma: a clinicopathologic study Cancer Cytopathol 118 2010 259
17. K.C. Halling, W. King, I.A. Sokolova A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma J Urol 164 2000 1768
18. L. Bubendorf, B. Grilli, G. Sauter Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings Am J Clin Pathol 116 2001 79
19. M.F. Sarosdy, P. Schellhammer, G. Bokinsky Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer J Urol 168 2002 1950
20. J.P. Stein, G. Lieskovsky, R. Cote Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients J Clin Oncol 19 2001 666